IHH Healthcare Berhad, listed on the Kuala Lumpur Stock Exchange under the stock symbol IHH, is a leading integrated healthcare provider with operations across Malaysia, Singapore, Turkey, India, China, and other international markets. The company is involved in primary, secondary, and tertiary healthcare services, and operates several well-known hospital brands such as Gleneagles and Mount Elizabeth.
Over the past 12 months, IHH Healthcare’s stock has risen by 23.63%, with a 52-week trading range of MYR 5.75 to MYR 7.37. The company reported MYR 23.17 billion in revenue and a net income of MYR 2.65 billion. IHH also has a PE ratio of 23.99 and a dividend yield of 1.39%, reflecting a stable financial position and investor confidence. The company is positioned well for continued growth, especially with plans to expand hospital bed capacity